Drawing for CYTOCHIP

USPTO serial 87231661

CYTOCHIP

Reviewed by CopyMark Law Group

Reg. 5292834Status 702Renewal
Filing date
Status date
Registration date
Sep 19, 2017
Examiner
PARK, JENNY K
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CYTOCHIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anna M. Quinn

Anna M. Quinn AVEK IP, LLC7285 W. 132nd St.Suite 340Overland Park, KS 66213

Goods and services

ClassDescriptionStatusFirst use
010Cytometers for medical diagnostic use; Diagnostic apparatus for the detection of cancer; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Hematology analyzers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical device for detecting cancer; Medical device for treating cancer; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical diagnostic apparatus for detecting cancer; Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic uses; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Flow cytometers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unitACTIVENov 9, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Sep 16, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Aug 25, 2025COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 27, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Apr 11, 2025PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Apr 7, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 7, 2024ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jun 4, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 4, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 4, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 28, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Sep 19, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 19, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 12, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 11, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 22, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 21, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 22, 2017IUAFUSE AMENDMENT FILED—
Jun 22, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 4, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 18, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 5, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2017DOCKASSIGNED TO EXAMINER—
Nov 16, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Nov 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance